These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2020807)

  • 1. Sources of confounding in immunologic data.
    Herberman RB
    Rev Infect Dis; 1991; 13 Suppl 1():S84-6. PubMed ID: 2020807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of a laboratory stressor on natural killer cell function in chronic fatigue syndrome patients.
    Wemm KM; Trestman RL
    Psychosomatics; 1991; 32(4):470-1. PubMed ID: 1961870
    [No Abstract]   [Full Text] [Related]  

  • 3. Natural killer cells and natural killer cell activity in chronic fatigue syndrome.
    Whiteside TL; Friberg D
    Am J Med; 1998 Sep; 105(3A):27S-34S. PubMed ID: 9790479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychoneuroimmunology and Natural Killer Cells: The Chromium-Release Whole-Blood Assay.
    Fletcher MA; Barnes Z; Broderick G; Klimas NG
    Methods Mol Biol; 2018; 1781():209-220. PubMed ID: 29705850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunodysregulation and chronic fatigue syndrome.
    Kundu SK; Ahronheim GA; Menezes J
    Can Dis Wkly Rep; 1991 Jan; 17 Suppl 1E():49-50. PubMed ID: 1669353
    [No Abstract]   [Full Text] [Related]  

  • 6. Chronic fatigue syndrome and immune dysfunction: cause or effect?
    Pollack S
    Isr Med Assoc J; 2002 Nov; 4(11 Suppl):883-5. PubMed ID: 12455171
    [No Abstract]   [Full Text] [Related]  

  • 7. Decreased natural killer cell activity is associated with severity of chronic fatigue immune dysfunction syndrome.
    Ojo-Amaize EA; Conley EJ; Peter JB
    Clin Infect Dis; 1994 Jan; 18 Suppl 1():S157-9. PubMed ID: 8148445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding clinical immunological testing in alleged chemically induced environmental illnesses.
    Salvaggio JE
    Regul Toxicol Pharmacol; 1996 Aug; 24(1 Pt 2):S16-27. PubMed ID: 8921551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chronic fatigue immune dysfunction syndrome].
    Uchida A
    Nihon Rinsho; 1992 Nov; 50(11):2625-9. PubMed ID: 1287238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of T and NK Cell Phenotype With the Diagnosis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).
    Rivas JL; Palencia T; Fernández G; García M
    Front Immunol; 2018; 9():1028. PubMed ID: 29867995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low NK syndrome and its relationship to chronic fatigue syndrome.
    Aoki T; Miyakoshi H; Usuda Y; Herberman RB
    Clin Immunol Immunopathol; 1993 Dec; 69(3):253-65. PubMed ID: 8242898
    [No Abstract]   [Full Text] [Related]  

  • 12. ERK1/2, MEK1/2 and p38 downstream signalling molecules impaired in CD56 dim CD16+ and CD56 bright CD16 dim/- natural killer cells in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients.
    Huth TK; Staines D; Marshall-Gradisnik S
    J Transl Med; 2016 Apr; 14():97. PubMed ID: 27098723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review of laboratory findings for patients with chronic fatigue syndrome.
    Buchwald D; Komaroff AL
    Rev Infect Dis; 1991; 13 Suppl 1():S12-8. PubMed ID: 1902321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural killer cytotoxicity in the diagnosis of immune dysfunction: criteria for a reproducible assay.
    Whiteside TL; Bryant J; Day R; Herberman RB
    J Clin Lab Anal; 1990; 4(2):102-14. PubMed ID: 2179501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stress-associated immune modulation: relevance to viral infections and chronic fatigue syndrome.
    Glaser R; Kiecolt-Glaser JK
    Am J Med; 1998 Sep; 105(3A):35S-42S. PubMed ID: 9790480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterisation of cell functions and receptors in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME).
    Hardcastle SL; Brenu EW; Johnston S; Nguyen T; Huth T; Wong N; Ramos S; Staines D; Marshall-Gradisnik S
    BMC Immunol; 2015 Jun; 16():35. PubMed ID: 26032326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The actual issues of comparing the results of quantitative immune-enzyme tests].
    PKuvshinov MV; Obriadina AP
    Klin Lab Diagn; 2012 Apr; (4):32-5. PubMed ID: 22768715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Standardization of in vitro methods.
    Yman L
    Allergy; 2001; 56 Suppl 67():70-4. PubMed ID: 11298014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency of deviant immunological test values in chronic fatigue syndrome patients.
    Natelson BH; Ellis SP; Braonáin PJ; DeLuca J; Tapp WN
    Clin Diagn Lab Immunol; 1995 Mar; 2(2):238-40. PubMed ID: 7697537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acceptance quality checks for qualitative fecal immunochemical tests ensure screening program consistency.
    McDonald PJ; Anderson CM; Fraser CG
    Int J Cancer; 2011 Jan; 128(1):247-8; author reply 248-9. PubMed ID: 20232391
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.